Martingale Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-159,603
| Closed | -$1.03M | – | 776 |
|
|
2023
Q2 | $1.03M | Sell |
159,603
-22,504
| -12% | -$145K | 0.02% | 439 |
|
|
2023
Q1 | $1.37M | Buy |
182,107
+60,240
| +49% | +$454K | 0.03% | 357 |
|
|
2022
Q4 | $1.23M | Buy |
121,867
+72,216
| +145% | +$732K | 0.02% | 399 |
|
|
2022
Q3 | $492K | Buy |
49,651
+22,800
| +85% | +$226K | 0.01% | 625 |
|
|
2022
Q2 | $286K | Buy |
+26,851
| New | +$286K | 0.01% | 740 |
|